EpiVax Oncology
Providence, US · Founded 2017
Biotech
Founders & leadership
WM
William MartinExecutive Officer, Director
GB
Gad BerdugoExecutive Officer
AD
Anne De GrootExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$425KraisedFeb 2021 · 6 investors · Biotechnology
Rule 506(b)$369.9KraisedFeb 2021 · 16 investors · Biotechnology
Rule 506(b)$375KraisedOct 2019 · 5 investors · Biotechnology
Rule 506(b)$1.4MraisedDec 2018 · 14 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.